Elliot Wilbur

Stock Analyst at Raymond James

(1.92)
# 3,166
Out of 5,154 analysts
55
Total ratings
33.33%
Success rate
5.41%
Average return

Stocks Rated by Elliot Wilbur

ADMA Biologics
May 8, 2025
Maintains: Strong Buy
Price Target: $25$32
Current: $15.70
Upside: +103.82%
ANI Pharmaceuticals
Sep 18, 2024
Maintains: Outperform
Price Target: $81$83
Current: $75.60
Upside: +9.79%
Sol-Gel Technologies
Aug 19, 2024
Downgrades: Outperform
Price Target: $60$40
Current: $79.00
Upside: -49.37%
Organon & Co.
Mar 16, 2023
Initiates: Outperform
Price Target: $33
Current: $6.71
Upside: +391.80%
Perrigo Company
Mar 6, 2023
Maintains: Outperform
Price Target: $42$43
Current: $11.20
Upside: +283.93%
PolyPid
Sep 6, 2022
Downgrades: Outperform
Price Target: $450$120
Current: $4.23
Upside: +2,736.88%
Viatris
Mar 1, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $14.53
Upside: -
Teva Pharmaceutical Industries
Oct 28, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $31.75
Upside: -
Zoetis
Jul 16, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $122.23
Upside: -
Elanco Animal Health
Jan 10, 2020
Initiates: Market Perform
Price Target: n/a
Current: $23.92
Upside: -
Upgrades: Market Perform
Price Target: n/a
Current: $7.85
Upside: -
Downgrades: Market Perform
Price Target: n/a
Current: $20.44
Upside: -